Skip to content

Systematic study of azelastine hydrochloride in human nasal epithelial cell model constructed from the bank of human nasal epithelial stem cell

Systematic study of azelastine hydrochloride in human nasal epithelial cell model constructed from the bank of human nasal epithelial stem cell

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16010200
Enrollment
Unknown
Registered
2016-12-21
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis

Interventions

Histamine stimulation group:Histamine stimulation
Azelastine hydrochloride Group:Treatment with azelastine hydrochloride
Allergen stimulation group:Allergen stimulation
Bacterial stimulation group:Bacterial product stimulation and treatment in cells culture
Virus stimulation group:Viral product stimulation and treatment in cells culture

Sponsors

Hong Haiyu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adult patients(18-60 years old) diagnosed with CRSwNP and CRSsNP, according to the Chinese and European Position Paper on Rhinosinusitis and Nasal Polyps, were recruited and they had undergone functional endoscopic sinus surgery (FESS) as part of the management for their disease at the Otolaryngology and Head Neck Surgery Department of the 5th Affiliated Hospital of Sun Yat-sen University.

Exclusion criteria

Exclusion criteria: Patients were excluded from the study if they had treatment with antibiotics or corticosteroids within a 4-week period before surgery, unilateral disease, allergic fungal rhinosinusitis, antrochoanal polyps, or cystic fibrosis.

Design outcomes

Secondary

MeasureTime frame
Epithelial cytokines;marker of mucosal epithelial pathway;

Primary

MeasureTime frame
Th2 inflammatory factors;Th1 inflammatory factors;Th17 inflammatory factors;marker of Apoptosis;marker related mucosa;

Countries

China

Contacts

Public ContactHong Haiyu

5th Hospital Affiliated with Sun Yat-sen University

sumshhy@139.com+86 13823070089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026